Novel aroylimidazolones

Aroylimidazolones

Aroylimidazolone

Abstract

This invention relates to certain substituted aroylimida- zolones, their acid and base addition salts thereof, and to their use as cardiotonic agents.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (3)

    Publication numberPublication dateAssigneeTitle
    EP-0058435-A2August 25, 1982Merrell Dow Pharmaceuticals Inc.4-Aroylimidazol-2-one
    EP-0059948-A1September 15, 1982Merrell Dow Pharmaceuticals Inc.Aroyl-imidazolones
    EP-0065165-A1November 24, 1982Merrell Dow Pharmaceuticals Inc.5-Oxymethyl-4-acyl-1,3-dihydro-2H-imidazol-2-one

NO-Patent Citations (0)

    Title

Cited By (5)

    Publication numberPublication dateAssigneeTitle
    EP-0264729-A2April 27, 1988Berlex Laboratories, Inc.Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-[4-(2-methyl-1H-imidazol-1-yl)-benzoyl]]-2H-imidazol-one
    EP-0264729-A3October 11, 1989Berlex Laboratories, Inc.Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-û4-(2-methyl-1h-imidazol-1-yl)-benzoyl¨¨-2h-imidazol-one
    EP-0284925-A2October 05, 1988Merrell Dow Pharmaceuticals Inc.Utilisation d'Imidazol-2-thiones pour la préparation d'un médicament pour réduire l'engourdissement du myocarde
    EP-0284925-A3June 13, 1990Merrell Dow Pharmaceuticals Inc.Verwendung von Imidazol-2-thionen zur Herstellung eines Arzneimittels zur Verringerung von 'Stunning' des Myokardiums
    US-4999365-AMarch 12, 1991Merrell Dow Pharmaceuticals Inc.Method of reducing reperfusion injury with imidazol-2-thiones